Pulse

PLSE NASDAQ
12.04
+0.18
+1.52%
After Hours: 12.04 0 0.00% 17:55 06/24 EDT
Open
11.89
Prev Close
11.86
High
12.30
Low
11.71
Volume
38.94K
Avg Vol (3M)
51.95K
52 Week High
19.77
52 Week Low
8.60
% Turnover
0.19%
Market Cap
249.35M
1D
5D
1M
3M
1Y
5Y

Company Profile

Pulse Biosciences, Inc. is a clinical-stage medical device company using a platform technology called Nano-Pulse stimulating (NPS). NPS is a non-thermal, precise, focal drug-free electroceutical treatment technology that initiates cell death within treated tissue. NPS provides treatment in a range of immuno-oncology, dermatology and aesthetic applications. It offers treatment for minimally invasive applications, such as cardiac ablation, lung disease, Barret's esophagus, thyroid nodules, and ear, nose and throat (ENT) papillomas. The Company is developing PulseTx system (PulseTx), a system for the delivery of NPS treatments. The PulseTx system delivers NPS pulses through its tunable pulse generator and its planned suite of electrodes. The PulseTx system pulses are applied directly to tissue through electrodes, creating transient nanometer pores in cell and organelle membranes.
MORE >

Recently

Name
Price
%Change